学会発表(海外)

学会発表(海外)

2024

  • Hiroki Kondo, Tetsuo Koshizuka and Keita Takahashi :
    Analysis of Antiviral Compounds Targeting Herpesvirus Transcriptional Regulatory Factors.48th Annual International Herpesvirus Workshop, 13-17 July 2024, Portland, Oregon
  • Yuhki Kobayashi, Hiroki Kondo, Keita takahashi, Naoki Inoue and Tetsuo Koshizuka:
    Characterization of guinea pig cytomegalovirus GP117 gene that encodes the Fc-gamma receptor homolog. 48th Annual International Herpesvirus Workshop, 13-17 July 2024, Portland, Oregon

2023

  • Haruka Sudo, Ayato Tsujii, Hina Oikawa, Nagisa Tokunoh, Sarana Kawashima, Yuta Hayakawa, Hiroki Fukushima, Keita Takahashi, Naoki Inoue, Tetsuo Koshizuka:Bacterium-like particles as a promising adjuvant for nasal vaccines targeting intestinal infections.17th Vaccine Congress, 24-27 September 2023, Glasgow, Scotland,2023.9.24-27.

2019

  • Keita Takahashi: Identification of cellular targets for DNA delivery from recombinant L.lactis strains in vivo.European society of gene&cell therapy 27th annual congress,Barcelona Spain,2019.10.22-25.

2018

  • Inoue N. Congenital CMV-related diagnostics prenatal vs perinatal care vs postnatal care. Workshop on Cytomegalovirus Infection: Advancing Strategies for Prevention and Treatment. Bethesda (USA), 2018.9.4-6.

2017

  • Takuya Miura,Miku Matsuura,Masashi Sakamoto,Akihiro Okumura,Miei Takeda,Souichi Yamada,Shinji Watanabe,Kohei Yamada,Naoki Inoue: Guinea pig CMV Gp129/131/133,homologs of human CMV UL128/130/131A,have a difference in requirements for infection of monocytes/macrophages and epithelial cells.The 42nd Annual International Herpesvirus Workshop,Ghent,Belgium,2017.7.29-8.2

2016

  • Tsuyoshi Sugiyama: ARHGEF15 augments TRIF-dependent pathway of TLR signaling via enhancing the phosphorylation of IRF-3.14th Biennial Meeting International Endotoxin and Innate Immunity Society,,Hambrug,Germany,2016.9.22-24


このページのトップへ戻る

2014

  • (invited lecture) Inoue N:
    The two wheels for infection control of VZV diseases: quality control of vaccine products and development of anti-VZV compounds. The 39th International Herpesvirus Workshop, Kobe,2014.
  • (poster) Taniguchi R, Koyano S, Suzutani T, Goishi K, Ito Y, Morioka I, Nakamura H, Yamada H, Oka A, Inoue N:
    A single nucleotide polymorphism in the NKG2D gene is associated with clinical outcome of congenital cytomegalovirus infection at birth. The 39th International Herpesvirus Workshop, Kobe,2014.
  • (poster) Yamada S, Fukuchi S, Hashimoto K, Katano H, Sato Y, Inoue N:
    Establishment of anex vivo culturing method for guinea pig placental tissues and analysis of virus spread in the tissues. The 39th International Herpesvirus Workshop, Kobe,2014.
  • Ebina Y, Minematsu T, Sonoyama A, Morioka I, Inoue N, Tairaku S, Nagamata S, Tanimura K, Morizane M, Deguchi M, Yamada H:
    The IgG avidity value for the prediction of congenital cytomegalovirus infection in a prospective cohort study. The 39th International Herpesvirus Workshop, Kobe,2014.
  • (poster) Liao H, Lee J-H, Kondo R, Katata M, Imadome K, Miyado K, Inoue N, Fujiwara S, Nakamura H:
    The highly conserved human cytomegalovirus UL136 ORF generates multiple Golgi -localizing protein isoforms through differential translation initiation. The 39thInternational Herpesvirus Workshop, Kobe,2014.
  • (poster) Kosughi I , Sakao-Suzuki M, Inoue N, Kawasaki H, Miyajima H, Iwashita T, Tsutsui Y:
    Aberrant macrophage/microglial reactions in the fetal cerebrum induced by cytomegalovirus infection. The 39th International Herpesvirus Workshop, Kobe,2014.

このページのトップへ戻る

2013

  • (oral) Hashimoto K, Fukuchi S, Yamada S, Fukui Y, Tsuda M, Kataoka M, Katano J, Inoue N:
    Guinea pig CMV GP129/131/133, homologs of HCMV UL128/130/131A, are required for entry into macrophages but not into fibroblast and epithelial cells. The 38th International Herpesvirus Workshop 2013 Grand Rapid, Michigan, 2013.

このページのトップへ戻る

2012

  • (oral) Yamada S, Fukuchi S, Hashimoto K, Katano H, Sato Y, Fukui Y, Inoue N:
    Effect of cytomegalovirus infection on placenta in a guinea pig model. International Federation of Placenta Association Meeting 2012, Hiroshima, 2012.
  • (oral) Hashimoto K, Yamada S, Fukuchi S, Katano H, Sato Y, Kato M, Moriishi K, Inoue N:
    Immunization of pregnant guinea pigs with glycoprotein B (gB). 4th Congenital CMV Conference & 14th International CMV/beta-herpesvirus Workshop, San Francisco, 2012.
  • (poster) Yamada S, Fukuchi S, Hashimoto K, Katano H, Sato Y, Inoue N:
    Establishment of an ex vivo culturing method for guinea pig placental tissues and analysis of virus spread in the tissues. 4th Congenital CMV Conference & 14th International CMV/beta-herpesvirus Workshop, San Francisco, 2012.
  • (poster) Koyano S, Inoue N, Moriuchi H, Nagamori T:
    Timing of specimen collection is critical for saliva-based screening programs for congenital cytomegalovirus infection. 4th Congenital CMV Conference & 14th International CMV/beta-herpesvirus Workshop, San Francisco, 2012.
  • (oral) Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, Shiboski S, Inoue N, Pereira L:
    Congenital cytomegalovirus infection identified in pregnancies complicated by idiopathic intrauterine growth restriction. 4th Congenital CMV Conference & 14th International CMV/beta-herpesvirus Workshop, San Francisco, 2012.
  • (poster) Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, Shiboski S, Inoue N, Pereira L:
    Congenital cytomegalovirus infection identified in pregnancies complicated by idiopathic intrauterine growth restriction. 4th Congenital CMV Conference & 14th International CMV/beta-herpesvirus Workshop, San Francisco, 2012.
  • (poster) Ebina Y, Sonoyama A, Morioka I, Tanimura K, Morizane M, Tairaku S, Minematsu T, Inoue N, Yamada H:
    Low IgG Avidity And Ultrasound Fetal Abnormality Predict Congenital Cytomegalovirus Infection. 4th Congenital CMV Conference & 14th International CMV/beta-herpesvirus Workshop, San Francisco, 2012.
  • (oral) Inoue N, Matsushita M, Fukui Y, Yamada S, Tsuda M, Higashi C, Kaneko K, Hasegawa H, Yamaguchi T:
    Inhibition of capsid assembly by a novel anti-VZV compound that targets the major capsid protein domain required for interaction with scaffold proteins. 37th International Herpesvirus Workshop, Canada, 2012

このページのトップへ戻る

2011

  • (oral) Inoue N, Matsushita M, Fukui Y, Tsuda M, Higashi C, Yamaguchi T:
    Identification and characterization of an antiviral compound that targets major capsid protein (ORF40) of varicella zoster virus. 14th International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections, Venice, Italy, 2011.
  • Inoue N, Matsushita M, Fukui Y,Tsuda M, Higashi C,Yamaguchi T:
    Identification and characterization of an antiviral compound that targets major capsid protein (ORF40) of varicella zoster virus. 15th International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections. Italy, October, 2011.
  • Inoue N, Matsushita M,Fukui Y,Tsuda M,Higashi C,Yamaguchi T:
    Identification of an antiviral compound that targets the varicella-zoster virus major capsid protein (ORF40). XV International Congress of Virology, Sapporo, September 2011.
  • Kiao H,Lee J.-H,Inoue N,Miyado K,Fujiwara S,Nakamura H:
    Characterization of human cytomegalovirus UL136 gene product. XV International Congress of Virology, Sapporo, September 2011.
  • Ikuta K,Ishioka K,Imamura T,Asano K, Yoshikawa T,Moriuchi H,Fujiwara S,Kubo T,Koyano S,Inoue N,Suzutani T:
    A genotypic and serologic study of cytomegalovirus (CMV) reinfection in mothers and neonates with congenital CMV infection in Japan. XV International Congress of Virology, Sapporo, September 2011.
  • Moriuchi M, Koyano S, Inoue N, Moriuchi H:
    Neonatal mass-screeninig on congenital cytomegalovirus infection in Nagasaki, Japan: a pilot study. XV International Congress of Virology, Sapporo, September 2011.

このページのトップへ戻る

2010

  • (oral) Inoue N,Koyano S,Yoshikawa T,Itoh Y,Moriuchi H,Asano K,Yamada H,Suzutani T,Fujieda K,for the Japanese Congenital Cytomegalovirus Study Group:
    CMV strains identified in urine specimens of almost all congenitally-infected newborns were identical to those of their siblings, suggesting siblings as the major risk factor for congenital infection in Japan. 2010 Congenital Cytomegalovirus Conference, Pari, 2010.
  • (oral) Koyano S, Inoue N, Oka A, Moriuchi H, Asano K, Yamada H, Itoh Y, Yoshikawa T, Fujieda K, for the Japanese Congenital Cytomegalovirus Study Group:
    Multi-center study on congenital CMV in Japan. 2010 Congenital Cytomegalovirus Conference, Pari, 2010.
  • (oral) Nakamura H, Liao H, Henmi C, Imadome K, Yajima M, Fujiwara S, Koyano S, Yoshikawa T, Moriuchi H, Suzutani T, Asano K, Ohishi T, Itoh Y, Taiji H, Inoue N, Fujieda K, for the Japanese Congenital Cytomegalovirus Study Group:
    Cellular immunological responses to CMV in congenitally CMV-infected infants identified by a pilot newborn CMV screening study in Japan. 2010 Congenital Cytomegalovirus Conference, Pari, 2010.
  • (poster) Moriuchi H, Morioka I, Yamada H, Imamura T, Asano K, Oka A, Itoh Y, Yoshikawa T, Koyano S, Inoue N, Fujieda K, for the Japanese Congenital Cytomegalovirus Study Group:
    A Multi-center study on the treatment of congenital CMV in Japan. 2010 Congenital Cytomegalovirus Conference, Pari, 2010.

このページのトップへ戻る